<DOC>
	<DOCNO>NCT01279850</DOCNO>
	<brief_summary>The objective investigation evaluate safety efficacy long term use Lyrica medical practice . Also , occurrence unknown known adverse drug reaction ( ADRs ) subject treat Lyrica monitor survey period , whether additional treatment outcome investigation and/or post-marketing clinical study require future determine .</brief_summary>
	<brief_title>Safety And Efficacy In Long Term Use Of Lyrica ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description>Patients fulfill criterion : 1 . Patients previously enrol A0081261 . 2 . Patients administer Lyrica 52 week .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients need administer Lyrica 52 week order enrol surveillance . Patients administer Lyrica .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Lyrica</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan</keyword>
	<keyword>Safety</keyword>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Post Marketing Surveillance</keyword>
</DOC>